Neuralace Medical

AXON THERAPY mPNS® FOR PATIENTS

Relief for Chronic Neuropathic Pain Without Surgery

A non-invasive treatment with no incisions, injections, implants, or ablations.
Discover the first and only FDA-cleared non-invasive magnetic peripheral nerve stimulation (mPNS) treatment for chronic neuropathic pain.

EXPERIENCE THE BREAKTHROUGH OF AXON THERAPY mPNS

How Axon Therapy Works

Axon Therapy mPNS is a non-invasive treatment that uses magnetic peripheral nerve stimulation to target chronic neuropathic pain. It js performed in the office, requires no incisions or implants, and involves no downtime after treatment.

Axon Therapy at a Glance

0 %

Non-invasive and painless spot treatment 

0 %
Avg. pain reduction after complete treatment protocol 1
0 %
Avg. pain reduction after just one treatment 1
0 min
Avg. time per treatment in established protocol
0
High-frequency magnetic pulses delivered per treatment

1For respondent patients only, VA Augusta Clinical Equipment Evaluation (CEC)

PATIENT BENEFITS

A Non-Invasive Treatment Option for Chronic Neuropathic Pain

For patients living with chronic neuropathic pain, including post-surgical pain, post-traumatic pain, painful diabetic neuropathy, and phantom limb pain, Axon Therapy mPNS offers a non-invasive treatment option that uses magnetic peripheral nerve stimulation. Treatment is performed in the office with no incisions, no implants, and no downtime after treatment. Discover the first and only FDA-cleared non-invasive magnetic peripheral nerve stimulation (mPNS) treatment for chronic neuropathic pain.

Chronic Neuropathic Pain Treatment Without Surgery or Implants

Axon Therapy mPNS is a non-invasive treatment for chronic neuropathic pain. It does not require incisions, implanted devices, or surgery. During treatment, the device is positioned near the skin to deliver magnetic pulses to the affected nerve area. Treatment is performed in the office and does not require downtime afterward.

Short In-Office Treatments for Chronic Neuropathic Pain

Axon Therapy mPNS treatments are performed in the office and take about 13.5 minutes per session. Treatment does not require incisions, implants, or downtime afterward.

For respondent patients, pain reduction may begin after the first treatment and continue throughout the treatment cycle.

In clinical evaluation, respondent patients reported an average 48% reduction in pain after one treatment, 70% after three treatments, and 87% after completing treatment.¹

Looking for a Non-Invasive Option for Chronic Neuropathic Pain?

Chronic neuropathic pain is often treated with medications, injections, or more invasive procedures. Axon Therapy mPNS offers a non-invasive treatment option performed in the office, without incisions, implants, or surgery. For patients looking for an alternative approach to chronic neuropathic pain treatment, Axon Therapy provides a different path to care.

Doctor Reviews

SIMPLE TREATMENT PROTOCOL

The Axon Therapy mPNS Treatment Schedule

With a series of 13.5-minute painless outpatient treatments delivered across 90 days, the Axon Therapy mPNS treatment protocol couldn’t be simpler.

Month 1

Week 1: Three Treatments
One treatment per day for three consecutive days
Week 2-4: Weekly
One treatment per week

Month 2

Month 2: Bi-Weekly
Two treatments every Two weeks (bi-monthly)

Month 3

Month 3+: Monthly
One treatment per month

ABOUT US

With Every Magnetic Pulse, We’re Changing Lives.

Meet the team employing painless magnetic pulses to revolutionize chronic neuropathic pain management for patients and healthcare providers.
Find Out More About Axon Therapy mPNS

Keith Warner

Chief Executive Officer

Proactive and engaging leader with expertise in advanced strategy development and implementation driving outstanding corporate growth. Over 25 years of senior level business acumen gained through key executive positions with leading large cap to venture stage startups within the life sciences and medical technology sectors. Experience in organization-building geared to achieve near and long term milestones both in domestic and international settings. Ability to deliver significant transformation and growth in financial performance, product development, investor fundraising, capital restructuring, P&L management, and strategic planning.